BioLife Solutions, Inc.
BLFS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -42.6% | 87.9% | -36% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 65.3% | 32.6% | 70.6% | 31.7% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 1.9% | -31.6% | -162.9% | -14% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -24.5% | -46.4% | -183.4% | -7.5% |
| EPS Diluted | -0.44 | -1.52 | -3.29 | -0.23 |
| % Growth | 71.1% | 53.8% | -1,330.4% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |